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Abstract
Provision of effective contraception to HIV positive women of reproductive age is critical to 
effective management of HIV infection and prevention of both vertical and horizontal HIV 
transmission in developing countries. This exploratory retrospective study examines contraceptive 
use during the prolonged postpartum period in a sample of 285 HIV positive and HIV negative 
women who gave birth at four rural maternity clinics in a high HIV-prevalence region in 
Mozambique. Multivariate analyses show no significant variations by HIV status in contraceptive 
timing (mean time to first contraceptive use of 7.1 months) or prevalence (31% at time of survey) 
but detect a moderating effect of fertility intentions: while HIV status makes no difference for 
women wishing to stop childbearing, among women who want to continue having children or are 
unsure about their reproductive plans, HIV positive status is associated with higher likelihood of 
contraceptive use. Regardless of HIV status, virtually no condom use is reported. These results are 
situated within the context of a rapidly widening access to postpartum antiretroviral therapy in the 
study site and similar sub-Saharan settings.
Background and conceptualization
Promotion of family planning to avoid unintended pregnancies is critical for improving 
health and wellbeing of HIV positive women and for effective prevention of mother-to-child 
transmission of HIV (Andia et al., 2009; Habte & Namasasu, 2015; Petruney, Robinson, 
Reynolds, Wilcher, & Cates, 2008; Reynolds, Steiner, & Cates, 2005; Wilcher, Cates, & 
Gregson 2009). Yet, despite considerable overall advances in the provision of family 
planning services to both HIV positive and HIV negative women throughout sub-Saharan 
Africa, contraceptive use on the sub-continent remains limited (Darroch & Singh, 2013; 
Khan, Mishra, Arnold, & Abderrahim, 2007). In fact, in some countries contraceptive 
prevalence has recently stagnated and even declined, and unmet need for family planning in 
the region remains highest in the world (Cleland, Harbison, & Shah, 2014), with less than 
half of sub-Saharan women who said that they would like to stop or postpone childbearing 
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using contraception (Sedgh, Hussain, Bankole, & Singh, 2007). As a result, unintended 
pregnancies are common (McCoy et al., 2014; Singh, Sedgh, & Hussain, 2010), 
compromising the health and well-being of women, children, and families.
Postpartum contraceptive use is particularly low (Winfrey and Rakesh, 2014). It is often 
hindered by what is said to be traditional practice of prolonged post-partum abstinence; 
accordingly, health care providers rarely encourage couples to start contraception early 
because of perceived low risks of conception. Besides, the benefits of antenatal and early 
postnatal contraceptive advice for postpartum contraceptive uptake are still debated (e.g., 
Engin-Üstün et al., 2007; Glazer, Wolf, & Gorby, 2011; Smith, van de Spuy, Cheng, Elton, 
& Glasier, 2002). Yet postpartum contraception has considerable potential in preventing 
unwanted or mistimed early repeat pregnancies, especially in a context of rapidly eroding 
traditional post-partum practices (Cleland, Shah, & Daniele, 2015). Moreover, prenatal and 
perinatal periods, when many women are typically in frequent contact with health providers, 
offer ideal opportunities for effective family planning counselling (e.g., Rossier & Hellen, 
2014).
Evidence on the association of HIV status with fertility intentions and contraception is 
inconclusive. While several studies have argued that HIV positive women have lower 
fertility intentions and higher contraceptive use than their HIV negative counterparts (e.g., 
Bankole, Biddlecom, & Dzekedzeke, 2011; Hoffman et al., 2008; Marlow et al., 2015; Taulo 
et al., 2009), other research shows considerable variation in fertility intentions and 
contraceptive use of HIV positive individuals (Blanchard et al., 2011; MacQuarrie et al., 
2014; Nattabi et al., 2009). The increasing availability of antiretroviral therapy (ART) may 
affect the relationship between HIV status and reproductive intentions and behaviour. As 
access to ART widens, especially during antenatal and postnatal periods, it may boost 
fertility intentions and increase pregnancy incidence among seropositive women (e.g., 
Cooper et al., 2009; Kaida et al., 2010; Maier et al., 2009; Makumbi et al., 2011; Myer et al., 
2010; Smith & Mbakwem, 2007; Tweya et al., 2013).
Hypotheses
In this exploratory study, we examined postpartum initiation and subsequent use of modern 
contraception among HIV positive and negative women who gave birth in four clinics in 
rural southern Mozambique. Guided by the literature on the effects of the rapidly increasing 
penetration and routinization of antenatal and postnatal ART on fertility, we formulated and 
tested the following two hypotheses regarding the association of HIV status with postpartum 
contraceptive uptake and subsequent use and regarding the role of fertility intentions in 
shaping this association. Overall, given the strong encouragement that HIV positive women 
typically receive from health providers to use contraception, we hypothesized that 
seropositive women will start contraceptive use earlier after birth and will be more likely to 
use it in the long postpartum period, compared to seronegative women (Hypothesis 1). 
However, we also considered how the intention to stop childbearing may modify the 
association between HIV status and contraceptive use. We proposed that in the era of near-
universal access to postpartum ART, HIV positive women will not differ from HIV negative 
ones in long-term fertility intentions because access to and experience of ART expand their 
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perceived lifetime horizons. Yet, while increasingly resembling their negative peers in 
fertility expectations and plans, HIV positive women, encouraged by health providers, may 
see contraceptive use as a general health management strategy as well as a family planning 
tool. In contrast, for seronegative women contraception is a more straightforward instrument 
for achieving desired family size. Based on these propositions, we hypothesized that fertility 
intentions will affect the timing of postpartum contraceptive initiation and the likelihood of 
continuous use more strongly among HIV negative women than among their HIV positive 
counterparts (Hypothesis 2).
The setting
The data used in this study were collected in a district in Gaza Province in southern 
Mozambique in 2012–13. A former Portuguese colony that gained independence in 1975, 
Mozambique was mired in a devastating civil war for the first decade and a half of its 
independent existence. Since the end of the war in 1992 and the introduction of structural 
reforms in the early 1990s, Mozambique has generally experienced robust macroeconomic 
growth. Despite this growth, however, Mozambique remains one of the world’s poorest 
countries, with an annual GDP per capita of about USD 580 (World Bank, 2015). 
Mozambique is also among the world’s most affected countries by the HIV/AIDS epidemic, 
with the national HIV prevalence of 12–16% of the adult population, depending on the 
estimates. The province of Gaza, where data for this study were collected, has the highest 
estimated HIV infection rate in the country: 25–27% of adults aged 15–49 and as high as 
30% among women of that age range (Ministry of Health, 2009; 2014).
Fertility in Mozambique has been persistently high: according to the three Demographic and 
Health Surveys (DHS), the total fertility rate (TFR) was 5.6 in 1997, 5.5 in 2003, and 5.9 in 
2011 (National Institute of Statistics, 2013, p. 75). In Gaza province, the DHS data suggest a 
slight decline of TFR: from 5.9, to 5.4 in 2003, to 5.3 in 2011 (National Institute of 
Statistics, 2013, p. 76). According to the 2011 Mozambique DHS, modern contraceptive 
prevalence among women in union aged 15–49 was only 11%, the same level registered in 
the previous DHS conducted eight years earlier (National Institute of Statistics, 2013, p. 71; 
National Institute of Statistics, 2005, p. 98). In Gaza, contraceptive prevalence has been 
slightly higher than the national average, 18%, but has also remained unchanged between the 
two last DHS (National Institute of Statistics, 2013, p. 72; National Institute of Statistics, 
2005, p. 100). Prevalence of condom use, at 1%, was particularly low (National Institute of 
Statistics, 2005, p. 100). According to the 2011 DHS, 97% of mothers abstained from sex 
during the first two months after birth, with this percentage declining to 53% at 8–9 months 
after birth (National Institute of Statistics, 2013, p. 79).
The district where data for this study were collected is a typical land-locked, monoethnic, 
predominantly Christian district of Gaza province. The majority of its population of about 
200,000 lives in rural areas and is engaged in low-yield subsistence agriculture. The 
precarious nature of local agricultural production and proximity to South Africa, 
Mozambique’s much more developed neighbour, has resulted in high rates of male labour 
migration to that country (de Vletter 2007). In addition, the area has also been a source of 
migrants to other parts of Mozambique, especially the nation’s capital city of Maputo.
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At the time of data collection, there were 12 health clinics in the district that provided 
maternal and child health (MCH) and other medical services to the district’s population. All 
these facilities are part of the National Health Service (NHS) network and provide all MCH 
services, as well as HIV testing and ART, free of charge. The area has a relatively high 
coverage of institutional child deliveries—c.70% (Agadjanian, Yao, & Hayford, 2016); in 
addition, many of the women who happen to deliver outside a health clinic bring their 
newborns there for checkups and vaccinations early after the birth. The area has a very high 
coverage of antenatal care, with almost all pregnant women attending at least one antenatal 
consultation (Agadjanian, Yao, & Hayford, 2016). All pregnant women receiving antenatal 
and delivery care are routinely tested for HIV.
Family planning has been provided at all these facilities for many years following the 
standard Ministry of Health (MOH) guidelines. Initial family planning counselling is 
typically done at prenatal consultations and then at the first postpartum checkup between 3–
7 days after delivery. However, method-specific counselling is typically offered starting only 
at 4–6 weeks after birth (usually timed with the administration of the polio vaccine to the 
child). Although HIV positive and HIV negative women are offered the same array of 
contraceptive options, the Ministry of Health guidelines stress dual protection (i.e., 
consistent condom use along with another contraceptive method of choice) particularly for 
the former (Ministry of Health, 2014, p. 77). Reliable statistics on postpartum ART 
utilization in the district are not available, but observations at local clinics and extensive 
interactions with health practitioners and administrators suggest a near universal availability 
and a rapidly growing coverage.
Data and Method
Data
The data come from a survey of women who gave birth in four rural maternity clinics (or 
brought their newborns there shortly after birth) in 2010–2011. The four clinics included in 
the study are located in different parts of the district and were purposively selected to 
represent a range of clinic and community settings. Three of the clinics are of comparable 
patient load, with 231, 268, and 284 births, respectively, in a twelve-month period. These 
births were used as a sampling frame in each of these clinics. The fourth clinic is located in a 
more densely populated area and had a much heavier patient flow. For that reason, in the 
fourth clinic we sampled births only over a six-month period (during which the clinic 
reported 403 births). The sampling strategy was guided by our goal to explore variations in 
contraceptive uptake and use by HIV status; the sample therefore was not meant to reflect 
HIV prevalence among reproductively active women in the study area. We aimed to sample 
75 women from each clinic. Because this study was designed as an exploratory study, we set 
the target sample size based on the expected degree of heterogeneity in the sample (drawing 
on our previous research in the study area) and the field team’s capacity to track 
respondents, rather than on formal power calculations. In building each clinic’s sample, we 
first selected all HIV positive women who gave birth at that clinic during the reference time 
period. We then randomly selected HIV negative women from the list of seronegative 
parturients in each clinic to reach the target sample size. A reserve list of 15 randomly 
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selected HIV negative women per clinic was constructed at the same time to supplement any 
women from the main list who could not be located.
In 2012–13, interviewers attempted to locate selected women using information available in 
the clinic delivery records (name, village of residence, and date of delivery). Women from 
the main list who could not be located were replaced by women from the reserve list. The 
final localization rate averaged 65% across clinics, being the lowest (47.5%) for the biggest 
clinic located in the community with the largest population size and highest residential 
density. All the located women consented to participating in the study and were interviewed 
using a standardized questionnaire. In all, the final sample consisted of 285 valid cases, 
including 121 HIV positive women and 164 HIV negative women.
The survey instrument contained detailed questions covering women’s socioeconomic 
background, marital and household characteristics, health of the focal child and of the 
respondent, and their interactions with the health care institution. A separate module of the 
instrument was focused on women’s knowledge and experience of family planning, 
including questions on family planning counselling received during and after the focal 
pregnancy, timing of use of specific contraceptive methods, side-effects if any, reasons for 
discontinuation, etc. Importantly, to minimize interviewer biased, the survey content was 
HIV-neutral and interviewers did not know the HIV status of respondents. In addition to the 
survey of women, attempts were made to interview marital partners of those who were in 
marital partnership about the partners’ knowledge of and attitudes toward family planning 
use. However, mainly because of high levels of male labour mobility, only forty-two partner 
interviews were completed. The partner interview data are not used in this analysis because 
of their small and highly biased sample. Data collection was carried out in collaboration 
between Arizona State University (USA), Eduardo Mondlane University (Mozambique), and 
Women’s Forum (Mozambique). The study was approved by the Institutional Review Board 
of Arizona State University and the Ethics Board of the Ministry of Health (Mozambique).
Method
We first described modern contraceptive use and the timing of contraceptive uptake, 
(regardless of specific method) comparing women who were HIV positive at the time of the 
focal birth and those who were not. Survival to contraception initiation after the focal birth 
for the two groups of women was modelled according to their intention to stop childbearing. 
The intention to stop childbearing was operationalized as a dichotomy: women who did not 
want to have any more children were contrasted with women who wanted to have at least 
one additional child in the future or were not sure about their childbearing plans.
For multivariate analyses, a set of two proportional hazards (Cox) models were first fitted to 
predict the hazard of contraceptive initiation. The exposure to risk of first contraceptive use 
was measured in months since the focal birth and was censored at the time of new pregnancy 
or at the time of the survey interview if no pregnancy occurs before that. Then, two logistic 
regression models were fitted to predict modern contraceptive use at the time of the survey. 
In both Cox and logistic regression models, the predictors of interest were respondent’s HIV 
status at the time of focal delivery and her intention to stop childbearing. We used fertility 
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intentions stated at the time of survey for both the contraception initiation model and the 
current use model.
Although fertility intentions can change in response to changes in women’s circumstances 
and constraints, intentions to stop childbearing are likely to be relatively stable over the short 
term, especially in this sample of women who are, on average, in the middle of their 
reproductive span. The first model for each outcome of interest tested Hypothesis 1 and 
included only main effects. To test our hypothesis about moderating effects of fertility 
intentions on contraceptive uptake and use (Hypothesis 2), the second model in each set 
added interactions between HIV status and the intention to stop childbearing.
All the models included several characteristics of respondents and their households: age, 
number of children prior to focal birth, partnership status, education, church attendance, 
housing quality, and mobile phone ownership. The models also controlled for distance to 
clinic and antenatal family planning counselling, as well as for survival of the focal child. 




Table 1 presents the characteristics of the sample. Table 2 shows the descriptive statistics for 
the variables of interest for the entire sample and by HIV status. Although fully three-
quarters of respondents reported having received family planning counselling at a prenatal 
consultation or shortly after delivery (Table 1), only 41.4% of them said that they had used a 
modern contraceptive method, typically the hormonal pills or injectables, at least once since 
the focal birth. The share of ever-users was nearly the same among HIV positive and HIV 
negative women. Ever-users started using contraception on average at 7.1 months after the 
childbirth, again with no difference by HIV status.1 A third (33.7%) of non-pregnant women 
reported using a contraceptive method at the time of survey, with the percentage of current 
users among HIV positive women being somewhat higher than among HIV negative ones.2 
Finally, 51.9% of the respondents stated that they did not want to have any more children in 
the future, with this share being somewhat higher among HIV negative women.
Figure 1A displays Kaplan-Meier estimates of contraceptive initiation for women who were 
HIV positive and those who were HIV negative at the time of focal birth. Echoing the 
patterns displayed in Table 2, the timing of contraceptive initiation is almost identical for the 
two groups: among both HIV positive and negative women, contraceptive use starts 
1Notably, the median reported period of postpartum abstinence was about six months, and 15% of women in the sample reported not 
having sex for at least one year after the pregnancy. The median duration of postpartum amenorrhea was even longer, at nine months. 
Along with the data on timing of first postpartum contraceptive use, these figures suggest that postpartum abstinence and amenorrhea 
do not necessarily deter use of contraception. In fact, substantial proportions of eventual users began use before resuming sex (31%) or 
before having a first post-partum menstruation (47%) (these statistics are not shown in Table 2 but are available from the authors upon 
request).
2Only four respondents reported ever trying a male condom since the birth of the focal child and only two respondents were using 
condoms at the time of survey. It is possible that condom use was underreported in the survey, although our field observations and 
interviews with providers suggest that despite the vigorous promotion of condoms by health authorities, condom use in stable 
partnerships remains infrequent and sporadic.
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relatively early and most contraceptive uptake occurs within ten months of birth, with the 
mean time to first contraceptive use almost identical among the two categories of women 
(7.1 and 7.2 months among HIV positive and HIV negative women, respectively). In fact, 
women who do not start using contraception before the end of the first year after birth are 
very unlikely to use contraception at all.
Figure 1B subdivides each HIV status group into two subgroups: those who wanted to stop 
childbearing (50.4% and 53.1% of HIV positive and HIV negative respondents, respectively) 
and those who wanted to have another child or were not sure about their reproductive 
intentions (49.6% and 46.9%). It shows a considerable gap between the two subgroups of 
HIV negative women: as one would expect, women who did not want to have any more 
children were more likely to start contraception earlier than women who wanted to continue 
childbearing or were undecided. However, this pattern is absent among HIV positive 
women: their contraceptive uptake does not seem to be affected by fertility intentions.
Multivariate results
The results of a multivariate proportional hazard (Cox) event-history model predicting the 
hazard of contraceptive initiation are displayed in Table 3, Section 1A, as parameter 
estimates and corresponding standard errors. Paralleling the bivariate results presented 
earlier, the effect of HIV status is very small in magnitude and not statistically significant. 
Model 1B adds the HIV status-fertility intentions interaction term. In this model, the 
coefficients for both the main effects of the two variables and for the interaction term are 
significantly different from zero. As these results show, being infected with HIV 
significantly increases the hazard of contraceptive initiation for women who want to have 
another child or are unsure about their future reproductive plans (β =0.64). The main effect 
of not wanting another child, which now represents HIV negative women, is large in 
magnitude and highly significant (β=1.18; p<0.01), echoing the pattern displayed in Figure 
1B. However, the interaction between being seropositive and wishing to stop childbearing is 
negative, statistically significant, and relatively large in magnitude (β= −1.28). That is, 
among seropositive women the net association of wanting no more children with 
contraceptive use is close to zero (1.18 + (−1.28)).
Sections 2A and 2B of Table 3 display the results of two logistic regression models 
predicting the probability of contraceptive use at the time of survey from the same set of 
covariates. The results are similar to those of the event history analysis, suggesting that the 
factors associated with contraceptive uptake also predict continuation of use. While the main 
effects-only model shows no statistically significant difference between HIV positive and 
negative women, in the model with the interaction term (2B), the main effect of being HIV 
positive, β =1.23, which now represents HIV positive women wishing to have more children 
or those unsure about their reproductive plans, is positive and statistically significant, 
corresponding to 3.42 times higher odds of using a contraceptive method compared HIV 
negative women with similar fertility intentions (OR=exp(1.23)=3.42). In this model, the 
main effect of wanting no more children, now representing HIV negative women wishing to 
stop childbearing, is also positive, large, and statistically significant, with β=1.99 and the 
corresponding odds ratio of 7.30. The interaction term is significant and negative, β= −1.82. 
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As in the previous model, the net effect of wanting to stop childbearing is close to zero 
among HIV positive women (1.99 + (−1.82)).
Among other covariates, age and number of children show no significant associations with 
the hazard of contraceptive initiation; nor are they significantly related to the likelihood of 
current contraceptive use. Partnership status is not significant in either pair of models. In 
comparison, the effect of respondent’s education is positive; notably, however, only the 
contrast between the lowest and highest educational levels is statistically significant at 
p<0.05. Household material conditions, represented by the type of roof and mobile phone 
ownership, show no effect on either outcome. Interestingly, women who attended church 
were significantly more likely to be using contraceptives than women who did not, echoing 
the finding of an earlier study in this part of Mozambique (Agadjanian, 2013). Having 
received family planning advice in the antenatal and perinatal periods is associated with both 
earlier contraceptive initiation and higher likelihood of current use. The effect of distance to 
clinic of delivery on both contraceptive initiation and current use is also in the expected 
direction, but it is not statistically significant at the conventional threshold.
Discussion and Conclusion
The foregoing analysis produced an instructive picture of postpartum contraception in this 
rural sample. Overall, reported contraceptive use – overwhelmingly oral or injectable 
hormonal methods – did not vary by HIV status and was relatively high compared to the 
DHS estimate for Gaza Province. Most users reported having initiated contraception within 
the first ten months of birth. Interestingly, much contraceptive use starts during postpartum 
abstinence and before the resumption of menstruation after childbirth. This pattern 
contradicts the widely held assumption that postpartum amenorrhea and abstinence are 
barriers to contraceptive uptake in sub-Saharan settings and requires further investigation. At 
the same time, the very low reported use of condoms, regardless of HIV status, which 
conforms to DHS data (National Institute of Statistics, 2013, p.100) and parallels evidence 
from some other resource-limited sub-Saharan settings (e.g., Ngure et al., 2012; Peltzer, 
Chao, & Dana, 2009), is a reason for concern, especially in light of the MOH continuous 
efforts to promote condom use for HIV prevention among HIV negative couples and as part 
of dual protection among HIV-affected couples.
Contrary to Hypothesis 1, there were no overall differences between HIV positive and 
negative women in timing of contraceptive initiation or in likelihood of using contraception. 
However, the results did point to a moderating effect of reproductive intentions on the 
association between HIV status and contraceptive uptake and use, thus lending support to 
Hypothesis 2. These results suggest that contraception is an important instrument for 
pursuing reproductive goals among seronegative women who want to end childbearing. 
However, fertility intentions are not related to contraceptive initiation or use among 
seropositive women, who use contraception at similar levels regardless of whether they want 
to have another child in the future. Interestingly, both the risk of contraceptive initiation and 
the probability of continuing use among HIV positive women are somewhere in between the 
corresponding values for HIV negative women who wished to stop childbearing and HIV 
negative women who desired another child or were unsure about future reproductive plans.
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Our tentative interpretation of these results builds upon the “now-or-never” approach to HIV 
and fertility proposed by Hayford, Agadjanian, and Luz (2012). In that study, the authors 
argued that HIV positive women were more likely both to speed up childbearing and to end 
it altogether, compared to negative women; these seemingly contradictory tendencies 
reflected the widespread belief that childbearing is incompatible with HIV in the long run. 
We propose that these contradictory attitudes have gradually evolved as the increasing 
coverage and routinization of postpartum ART has expanded the life horizons of HIV 
positive individuals and transformed HIV from a stigmatized death sentence to a serious yet 
clinically and socially manageable health condition. This evolution diminishes differences in 
fertility intentions between HIV positive and negative women, and, in turn, affects the 
patterns of contraceptive initiation and use among the former. Thus, those HIV positive 
women who want to have another child may not feel an urgency to become pregnant early as 
they no longer expect their health to deteriorate quickly. With active encouragement from 
health providers and probably with support from their partners and significant others, these 
women may increasingly choose contraception as part of management of their HIV infection 
by waiting for the “right” time to get pregnant. A direct test of these explanations would 
require more detailed measures of fertility intentions, including measures of desired timing 
of birth, as well as detailed data on women’s interactions with providers, partners, and 
others. At the same time, the rate of contraceptive initiation and the likelihood of current use 
among seropositive women who wanted to stop childbearing were lower than among 
seronegative women with similar intentions. It is possible that the nature and strength of the 
stopping intention differ between HIV positive and negative women, but this proposition 
also needs further study with more specialized data.
Limitations of our exploratory study must be acknowledged. Our analysis relies on self-
reported contraceptive use, and as in any such study, reporting bias and accuracies may exist, 
especially with given the retrospective nature of the questions. The analysis is based on a 
relatively small sample from only four rural clinics. In order to maximize statistical power 
for the comparison of HIV positive and HIV negative women, HIV positive women were 
oversampled. Still, the sample may be underpowered for the detection of small-size effects, 
and thus caution must be exercised in interpreting weak statistical associations. HIV status is 
available only for the time of the focal child delivery. To minimize the interviewer bias and 
potential for misreporting, the survey instrument was HIV-neutral and did not include 
questions on ART. In this setting of high male labour mobility and increasing marital 
instability only a small and probably non-representative fraction of male partners could be 
interviewed and therefore the input of men into reproductive and contraceptive decisions 
could not be accounted for. While some covariates in the event-history model are time-
varying others could only be measured at the time of survey.
These limitations notwithstanding, our findings illustrate both the change and continuity of 
reproductive behaviour in the era of widespread access to ART. While rapidly increasing 
availability of ART greatly diminishes the differences in fertility between HIV positive and 
HIV negative women observed in earlier stages of the HIV/AIDS pandemic by increasing 
desires for additional children and pregnancy incidence among seropositive women, it does 
not completely eliminate doubts and concerns surrounding both short- and longer-term 
implications of the HIV status for both mother’s and child’s health and wellbeing (O’Shea et 
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al., 2016). Nor does it fully equip women and couples to deal with social and cultural 
pressures surrounding marriage, sex, and childbearing (Smith & Mbakwem, 2007). These 
uncertainties often result in inconsistent contraceptive use and lead to unplanned pregnancies 
(Laryea et al., 2014; Schwartz et al., 2012; Schaan, Taylor, & Marlink, 2014). Although our 
study focuses on only one high-prevalence sub-Saharan setting and cannot be readily 
generalized to the rest of the sub-continent, the results of the analysis propose an interesting 
and important avenue for further examination of reproductive and contraceptive itineraries in 
other rural sub-Saharan settings with high HIV prevalence and widening access to ART.
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Kaplan-Meier estimates of contraceptive initiation (survival to first contraceptive use since 
focal birth, in months)
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Table 1
Sample characteristics (percent unless otherwise noted)
Characteristic
HIV positive 42.5
Time since birth of focal child (months, mean) 22.3
Age (mean) 29.5
Number of children ever born (mean) 3.6
Focal child died 17.2
Became pregnant after focal child’s birth 13.3
Marital partnership
  No current partner 30.5
  Partner currently stays in same village 22.5
  Partner currently stays outside village 47.0
Education
  Never went to school 31.2
  Completed between 1 and 5 years of school 39.2
  Completed 6 or more years of school 29.5
Material conditions
  Residence roof made of zinc sheets or similar 55.8
  Has a mobile phone 48.8
Went to a church at least once in past two weeks 66.0
Distance from residence to clinic of focal birth
  Less than 3km 39.0
  3–7km 44.9
  8km or more 16.1
Received antenatal family planning counselling 75.1
Number of observations 285
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Table 2
Modern contraceptive use and intention to stop childbearing (percent)
Characteristic All HIV+ HIV−
Used a modern contraceptive method at least once since focal birth 41.4 41.3 41.5
Time to first modern contraceptive use since focal birth (months, mean) 7.1 7.2 7.1
Was using a modern contraceptive method at time of surveya 33.7 37.2 31.1
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